Insider Stock Trading History of Freyman Thomas C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Freyman Thomas C since year 2005. The trader's CIK number is 1239126. At the time of this reporting, Freyman Thomas C is the of Allergan Plc . (stock ticker symbol AGN). See this page for all insider trading activities at Allergan Plc .

Note that in the past FREYMAN THOMAS C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Freyman Thomas C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-08-30 AGN Allergan Plc Buy 1,100 190.69 209,759
2018-08-09 TEN Tenneco Inc Buy 5,000 44.49 222,450
2016-07-29 ABT Abbott Laboratories Option Ex 56,000 25.25 1,413,776
2014-07-21 ABT Abbott Laboratories Option Ex 79,000 23.23 1,835,407
2014-03-03 ABT Abbott Laboratories Sale 2,984 39.10 116,686
2013-10-21 ABT Abbott Laboratories Option Ex 42,487 34.93 1,484,070
2013-05-02 TEN Tenneco Inc Buy 1,500 38.26 57,390
2013-04-01 ABT Abbott Laboratories Option Ex 63,800 22.27 1,420,634
2013-03-12 ABT Abbott Laboratories Option Ex 49,564 25.67 1,272,357
2012-09-21 ABT Abbott Laboratories Option Ex 30,000 44.16 1,324,800
2012-07-23 ABT Abbott Laboratories Option Ex 30,000 44.16 1,324,800
2012-05-03 ABT Abbott Laboratories Option Ex 25,602 58.90 1,507,957
2012-03-20 ABT Abbott Laboratories Option Ex 52,273 53.61 2,802,355
2011-12-21 ABT Abbott Laboratories Option Ex 95,764 53.62 5,135,344
2011-08-05 ABT Abbott Laboratories Sale 20,000 49.19 983,800
2010-10-25 ABT Abbott Laboratories Sale 22,019 52.94 1,165,685
2010-07-26 ABT Abbott Laboratories Sale 20,000 49.17 983,500
2010-02-16 ABT Abbott Laboratories Sale 2,100 53.92 113,234
2010-02-01 ABT Abbott Laboratories Sale 23,500 53.35 1,253,819
2010-02-10 ABT Abbott Laboratories Sale 1,500 53.36 80,040
2009-11-11 ABT Abbott Laboratories Sale 20,000 53.50 1,070,000
2009-02-17 ABT Abbott Laboratories Sale 954 54.41 51,909
2009-02-04 ABT Abbott Laboratories Option Ex 20,882 52.55 1,097,349
2008-07-21 ABT Abbott Laboratories Option Ex 27,848 53.19 1,481,235
2008-02-05 ABT Abbott Laboratories Option Ex 2,012 54.62 109,895
2007-12-11 ABT Abbott Laboratories Option Ex 41,057 46.78 1,920,810
2007-11-30 ABT Abbott Laboratories Option Ex 64,784 45.45 2,944,303
2007-11-13 ABT Abbott Laboratories Option Ex 29,245 43.73 1,278,883
2007-08-08 ABT Abbott Laboratories Option Ex 19,507 41.03 800,391
2007-08-09 ABT Abbott Laboratories Option Ex 24,839 46.92 1,165,421
2007-03-27 ABT Abbott Laboratories Option Ex 41,621 45.45 1,891,591
2007-03-01 ABT Abbott Laboratories Option Ex 2,292 43.61 99,954
2007-01-31 ABT Abbott Laboratories Option Ex 31,920 42.50 1,356,504
2007-01-29 ABT Abbott Laboratories Option Ex 94,830 41.25 3,911,453
2007-01-29 ABT Abbott Laboratories Sale 1,845 52.57 96,991
2007-01-03 ABT Abbott Laboratories Sale 66 49.04 3,236
2007-01-03 ABT Abbott Laboratories Option Ex 17,828 46.92 836,471
2006-07-25 ABT Abbott Laboratories Option Ex 6,428 42.20 271,242
2006-02-15 ABT Abbott Laboratories Option Ex 35,468 33.23 1,178,637
2006-02-15 ABT Abbott Laboratories Sale 780 43.85 34,203
2006-01-30 ABT Abbott Laboratories Option Ex 23,224 41.97 974,734

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Freyman Thomas C ( of Allergan Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.